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Abstract
Background: In patients after aortic valve surgery, the quality of life is hypothesized to be influenced by the type
of the valve procedure. A cross-sectional study on the postoperative quality of life was carried out in patients after
aortic valve-sparing surgery (with regards to the age of the patient), Ross procedure and mechanical aortic valve
replacement.
Methods: Quality of life was studied in 139 patients after aortic valve surgery divided into four study groups
(Y – aortic valve-sparing procedure at the age below 50 years, mean age 36.2 years; O – aortic valve-sparing
procedure at the age 50 years and over, mean age 59.2 years; R – Ross procedure, mean age 37.8 years
and M – mechanical aortic valve replacement at the age below 50 years, mean age 39.2 years). SF-36 Short
Form and valve-specific questionnaires were mailed to the patients after 6 months or later following surgery
(median 26.9 months).
Results: In SF-36, the younger aortic valve repair patients and the Ross patients scored significantly better in
4 of 4 physical subscales and in 2 of 4 mental subscales than the older aortic valve repair and mechanical
valve replacement patients. In the valve-specific questionnaire; however, all 3 groups free of anticoagulation
(Y, O, and R) displayed greater freedom from negative valve-related concerns.
Conclusions: Postoperative quality of life is influenced by the type of aortic valve procedure and is negatively linked
with mechanical prosthesis implantation and long-term anticoagulation. Aortic valve-sparing strategy should be
considered in cases with suitable valve morphology due to favorable clinical results and beneficial impact on the
long-term quality of life.
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Background
Aortic valve-sparing procedures (AVS) represent currently
an appealing surgical strategy in the treatment of aortic
regurgitation (AR) with/without dystrophic aortic root
dilation. Although bearing an inherent uncertainty of the
durability of the repair the main rationale for attempting
valve-sparing surgery in patients with suitable morphology
is avoidance of the classical risks related to the valve re-
placement devices. This applies especially for younger
patients who otherwise would mostly be candidates for
mechanical valve with a lifelong burden of coumadin
administration. As a result of accumulated experience, a
certain degree of standardization and simplification of
surgical valve-sparing techniques allows a safe and pre-
dictable result. Low operative risk makes therefore the
AVS eligible also for older population of patients who
otherwise are believed to benefit from a bioprosthetic
valve replacement.
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Several studies report favorable early and midterm
clinical outcomes after AVS surgery [1–10]. Quality of
life (QoL), on contrary, is a complex and diverse value
which may poorly correlate with the clinical data. It is
hypothesized that, besides an improvement in clinical
outcome, there is a positive impact on QoL desired in
patients after AVS, as they are free of concerns related
to coumadin medication. We conducted a single center
cross-sectional survey to assess and compare the quality
of life in adult patients undergoing AVS, Ross procedure
and mechanical valve replacement.
Methods
The study was approved by the Institutional Review Board
of the University Hospital, Hradec Kralove. Between 2006
and 2012, a total of 1424 aortic valve procedures were
performed at our institution, comprising aortic valve re-
placement with/without replacement of the ascending
aorta, aortic valve-sparing procedures and Ross proce-
dures. The age of the patients ranged between 19 and
86 years. The time frame for patients’ recruitment was
deduced from the period of institutional started-up aortic
valve-sparing program (since 2007) and Ross program
(since 2009). To gather a comparable number of mech-
anical aortic valve replacement (AVR) patients, these
patients were enrolled already since 2006.
To be able to identify the possible impact of the chosen
type of aortic valve procedure on QoL in comparable
groups, all consecutive patients after valve-sparing and
Ross procedures were enrolled. With regard to the youn-
ger age profile of the Ross patients the patients after AVS
were divided into two age groups (delineated by the age of
50). For mechanical AVR, all consecutive patients below
the age of 50 and having an isolated aortic procedure
(valve w/or w/o root surgery) were enrolled. Thus, the
quality of life was studied in a total of 139 patients after
aortic valve surgery divided into four study groups:
1. Y – 36 patients after aortic valve-sparing procedure,
including aortic root procedure. Inclusion criteria:
age below 50 years (mean age 36.2 years, operated
2/2008–5/2012). From the original number of 41,
2 patients did not respond the questionnaires and
3 patients were excluded from the survey: one
patient died during follow-up from non-cardiac
reason and two were reoperated for the valve repair
failure.
2. O - 52 patients after aortic valve-sparing procedure,
including aortic root procedure. Inclusion criteria:
age 50 years and over (mean age 59.2 years, operated
11/2007–6/2012). From the original number of 56,
4 patients were excluded: one patient died 1.5 month
due to stroke and 3 were reoperated for the valve
repair failure.
3. R – 22 patients after Ross procedure (mean age
37.8 years, operated between 11/2009 and 8/2012).
No exclusion criteria.
4. M – 29 patients after AVR with a mechanical
prosthesis. Inclusion criteria: elective aortic valve
replacement - isolated or combined with ascending
aortic procedure at the age below 50. Exclusion
criteria: left ventricular ejection fraction below 50 %,
coronary artery disease or other cardiac procedure.
Mean age 39.2 years. Operated 3/2006–9/2012.
From the original number of 31, 2 patients did not
respond the questionnaires.
The type of the aortic valve surgery in each patient
was dictated by the valve and root pathomorphology
with a clear aim to prioritize the valve salvage. A conser-
vative aortic valve surgery was therefore performed in all
patients with pure AR in whom the pre-operative echo-
cardiography analysis and intraoperative valve assess-
ment allowed for the repair. The patients with pure AR
not eligible for repair (restrictive leaflet morphology) or
concomitant aortic valve stenosis (AS) were offered
valve replacement with a mechanical valve or a Ross
procedure. Ross procedure was suggested to patients
who clearly disapproved the coumadin solution, typic-
ally younger individuals with an active life-style. All
patients were informed in detail about all the surgical
modalities and their relevant advantages and drawbacks.
The patients themselves made the final decision for a
given procedure. Aortic valve- sparing procedures were
performed by 3 surgeons whereas the Ross procedure was
performed by a single surgeon.
Quality of life was assessed by means of mailed ques-
tionnaires to be filled without additional counseling. An
informed consent was obtained as an integral part of the
questionnaire. The questionnaires were sent to the pa-
tients no sooner than 6 months after the surgery. Short
Form Health Survey (SF-36) [11] and valve-specific ques-
tionnaire, as published by Perchinsky [12], were used as
survey tools. In general, in SF-36 there were 36 items ana-
lyzed in 8 subscales (physical functioning, physical role,
bodily pain, general health, vitality, social functioning,
emotional role, and mental health). Valve-specific ques-
tionnaire comprised of 8 questions on specific features of
life after valve surgery (question on being disturbed by the
sound of valve prosthesis was omitted as confusing in
Ross and AVS patients).
As mentioned above, 5 patients after AVS who required
reoperation for the valve repair failure were not sent the
questionnaires due to potential bias. The reasons of
failure were miscellaneous: progressive restriction of
the leaflets, tearing of the cusp plication, absence of
annular stabilization in isolated cusp repair, giant-cell
aortitis). Reoperations were performed after a mean
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interval of 21 months (7–60); all valves were replaced
with a zero mortality.
Statistical analysis
Continuous variables were described as mean ± SD and
categorical variables as counts and absolute and relative
frequencies. The comparisons between groups were per-
formed by Fisher´s Exact Test for categorical variables
and for SF-36 scoring results for intervals 100–90,
89–70, 69–50, 49–0. A p-value of 0.05 was used for
determining significant difference. NCSS statistical soft-
ware was used (NCSS, LLC Kaysville, Utah, USA).
Results
Patient population results
Patients’ demographic, preoperative and postoperative
clinical data are summarized in Table 1.
Patient age (excl. group O), sex, NYHA functional class,
left ventricular ejection fraction (EF) and advanced degree
of aortic regurgitation (AR) did not differ between the
groups. A high proportion of bicuspid aortic valve morph-
ology was marked in groups Y and M, while unicuspid
valvular morphology was extraordinary frequent in the
group R. At the follow-up, all groups achieved excellent
functional improvement in terms of NYHA class, residual
AR and EF, irrespective of the surgical procedure.
Procedural details
All procedures were performed via standard sternotomy
approach. Surgical strategy in valve-sparing groups (group
Y and O) was tailored according to the individual patient’s
morphology to correct the diameters of ventriculo-aortal
and sino-tubular junctions and to obtain equal effective
height of the aortic cusps (9–10 mm).
Surgical techniques involved cusp plication (25 and 28;
Y and O resp.), suture of the cleft in a bicuspid aortic
valve (8 and 6), or isolated supracoronary aortic replace-
ment (8 and 17). Complex root repair was required in
38 patients, accomplished by root reimplantation tech-
nique (David procedure) (9 pts.; 2 and 7; Y and O resp.),
root remodeling technique (Yacoub procedure) (27 pts.;
11 and 16) combined with Extra Aortic annuloplasty
ring (Coronéo Inc., Montreal, QC, Canada) (23 pts.; 11
and 12). Additional cardiac procedures were performed
in 24 pts. – Table 2.
Postoperative quality of life
SF-36 Short Form QoL questionnaire was completed by
139 patients (Y = 36, O = 52, R = 22, M = 29) at a median
of 26.9 months postoperative (range 6–73 months). The
questionnaire could not be obtained from 4 patients
(two after AVS and two after mechanical AVR). In gen-
eral, across all 8 subscales there were marked trends for
better performance of the group Y (younger aortic valve
repair) and R (Ross) against worse performance of the
group O (older aortic valve repair) and M (mechanical
AVR) – Table 3.
The specific valve related questionnaire was also com-
pleted by 139 patients (Y = 36, O = 52, R = 22, M = 29).
The response distribution with regard to 8 questions is
shown in Table 4. In response to four questions (impact
of follow-up care, visiting a physician, blood tests and
Table 1 Patients’ demographic and clinical data (preoperative
and follow-up)
Y (repair) O (repair) Ross M (mechAVR)
Preoperative: n = 36 n = 52 n = 22 n = 29
Age (years), ø ± SD 36.3 ± 6.1 59.2 ± 7.7 37.8 ± 11.9 39.7 ± 7.3
Males (%) 78 70 83 69
NYHA class (%)
I 50 23 48 41
II 39 55 39 45
III 11 23 13 14
IV 3 0 0 0
Bicuspid Ao-valve (%) 78 46 35 79
Unicuspid Ao-valve (%) 8 0 61 7
Marfan sy (%) 8 0 0 0
Art. hypertension (%) 39 64 22 31
Diabetes (%) 6 18 0 0
EF (%) 61 ± 8 58 ± 11 65 ± 8 65 ± 6
AR preop. (%)
Grade 0 3 2 0 7
1 11 9 13 14
2 6 9 4 14
3 8 15 4 3
4 72 64 78 62
AS severe (%) 0 0 36 45
At latest follow-up:
NYHA class (%)
I 94 75 100 100
II 6 25 0 0
III 0 0 0 0
IV 0 0 0 0
EF (%) 62 ± 6 61 ± 9 63 ± 5 65 ± 7
AR postop. (%)
Grade 0 47 38 22 0
1 32 38 61 0
2 12 19 9 0
3 0 2 4 0
4 3 4 0 0
AR aortic regurgitation, AS aortic stenosis, NYHA New York Heart Association
functional classification, EF left ventricular ejection fraction
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awareness of risk of complications) there were no signifi-
cant differences among the non-replacement responders
(Y, O, R). When these three groups were pooled together
and compared to the M group they showed significantly
greater freedom of valve-related life-style limitations.
Patients in the mechanical AVR group (M) were more
concerned by the risk of bleeding due to medication
than the non-replacement patients. In regard to the pos-
sible risk of reoperation, the younger repair patients (Y)
were more disturbed than the older ones (O).
Discussion
Aortic valve-sparing surgery is an attractive and challen-
ging surgical option which requires a focused interest
and training of a dedicated surgeon. Active attitude in
attempting the valve salvage is based on the surgeon’s
belief that reconstruction of the aortic valve opens an
opportunity to the patient to live without the burden of
long-term anticoagulation and its related risks, which
may provide a superior quality of life. This rationale
should support the decision for repair against the poten-
tial risk of perioperative failure (need for re-clamping) or
repair failure in postoperative period. In the recent dec-
ade, refinement of surgical techniques and systematical
methodological portfolio of steps has enabled to perform
aortic valve repair with a high prediction of success. As
a result, there is a continuum of aortic valve repair
candidates in whom three subpopulations can be identi-
fied. First, very young adult patients and women with
child bearing potential form the group with strongest
undebatable urge for valve conservation. The second
group concerns mid-aged (45–55 years) patients who
are facing the issue of sudden change of the life-style
related with the onset of anticoagulation due to mechan-
ical AVR. The third group comprises older patients whose
aortic valve morphology would allow a repair, but
otherwise qualify reasonably for a bioprosthesis (60–65
years of age).
Beside the known low procedural risk and good clin-
ical outcomes [1–8, 10, 13, 14], the expectation of a
superior quality of postoperative life might play a role in
decision for aortic valve-sparing strategy. Hypothetically,
better quality of life should result from the absence of
anticoagulation and related life-style limitations, aware-
ness of permanent risk of thromboembolic and bleeding
complications, absence of blood checking and vigilance
against prosthetic infection [15]. On the other hand, the
fear of a potential reoperation may affect negatively the
quality of life after valve-sparing aortic surgery.
Table 2 Surgical techniques used for aortic valve repair and
additional procedures
Y (repair) O (repair)
Repair techniques: n = 36 n = 52
Central plication of the leaflet 25 28
Suture of the cleft 8 6
Supracoronary aortic replacement 8 17
Yacoub procedure 11 16
David procedure 2 7
Annuloplasty ring 11 12
Additional procedures:
CABG 0 4
Mitral valve repair 3 4
Hemiarch replacement 1 5
MAZE 0 6
Tricuspid valve repair 0 1
CABG coronary artery bypass grafting, MAZE cryosurgical ablation for
atrial fibrillation
Table 3 QoL life scores assessed by Short Form Health Survey
(SF-36)
Y (repair) O (repair) Ross M (mechAVR)
n = 36 n = 52 n = 22 n = 29
Physical functioning 89.4 ± 13.1 70.7 ± 22.1 88.6 ± 19.3 82.5 ± 18.0
p-value Y >M 0.049
Y > O 0.0003
R > O 0.001
Role physical 78.1 ± 33.3 55.9 ± 42.7 86.9 ± 25.1 68.3 ± 39.6
p-value Y > O 0.015
R > O 0.002
Bodily pain 83.9 ± 22.6 71.1 ± 27.5 89.2 ± 17.3 78.2 ± 19.0
p-value M > O 0.044
R >M 0.023
R > O 0.022
General health 71.4 ± 17.9 55.9 ± 18.6 71.2 ± 22.7 53.5 ± 18.7
p-value Y > O 0.003
Y >M 0.002
R > O 0.005
R >M 0.013
Vitality 62.4 ± 19.7 54.9 ± 15.8 62.9 ± 16.1 54.8 ± 20.4
p-value Y > O 0.015
R > O 0.006
R >M 0.046
Social functioning 83.3 ± 22.6 74.3 ± 21.1 88.1 ± 21.3 77.4 ± 23.0
p-value Y > O 0.026
R > O 0.004
Role emotional 83.3 ± 31.9 65.7 ± 40.5 85.7 ± 28.3 73.1 ± 32.1
N.S.
Mental health 72.4 ± 18.6 70.1 ± 16.9 74.3 ± 16.0 65.8 ± 17.1
N.S.
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Table 4 QoL expressed in relation to specific valve related concerns, acc. Perchinsky (modif.) [12]
Y (repair) O (repair) Ross M (mechAVR)
n = 36 n = 52 n = 22 n = 29
(%) (%) (%) (%)
1. If you had to do it over again, would you chose the same procedure?
Yes 92 71 82 72
I don’t know 6 21 18 21
No 3 8 0 7
p value - N.S.
2. After the valve surgery, are you annoyed by the need of follow-up care?
Never/rarely 89 87 91 69
Occasionally 11 13 5 31
Frequently/always 0 0 0 0
p value Y vs O vs R - N.S.
(Y + O + R) vs M - 0,016
3. After the valve surgery, are you annoyed by visiting the doctor frequently?
Never/rarely 86 73 77 52
Occasionally 14 27 23 48
Frequently/always 0 0 0 0
p value Y vs O vs R - N.S.
(Y + O + R) vs M - 0,0088
4. Are you annoyed by frequent blood tests?
Never/rarely 92 77 86 34
Occasionally 6 19 9 52
Frequently/always 3 4 5 14
p value Y vs O vs R - N.S.
(Y + O + R) vs M - 0,00001
5. Are you disturbed the possibility of complications due to your implanted valve?
Never/rarely 42 58 64 24
Occasionally 53 42 27 66
Frequently/always 6 0 9 10
p value Y vs O vs R - N.S.
(Y + O + R) vs M - 0,0079
6. Are you disturbed by the risk of bleeding due to medication?
Never/rarely 78 73 86 31
Occasionally 8 27 9 55
Frequently/always 14 0 5 14
p value Y vs O vs R - 0,008
(Y + O + R) vs M - 0,00001
7. Are you disturbed by the risk of valve failure?
Never/rarely 53 65 68 55
Occasionally 39 33 27 38
Frequently/always 8 2 5 7
p value - N.S.
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Quality of life is a “soft” variable that is not easy to
measure. In our study, we used a combination of two
survey tools: a recognized and validated SF-36 question-
naire for a general assessment of QoL and a valve-specific
questionnaire describing the specific concerns of a patient
after valve surgery [11, 12].
Based on SF-36 results, from the three groups of a
comparable age (Y, R and M, mean age 36, 38, 40 years,
resp.) the younger valve repair patients and Ross patients
scored significantly better than the patients after mechan-
ical valve replacement in all four physical subscales and at
least in two of the four mental subscales. The older pa-
tients after valve-sparing surgery (mean age 59 years) did
not match the younger repair patients and had scores
comparable to the patients after mechanical AVR. The
most intuitive explanation for these results (physical
scores in particular) is the age difference.
The results of the valve-specific questionnaire yield a
different insight into the quality of life after valve sur-
gery. Despite even an age difference, all three groups
without mechanical replacement device enjoyed greater
freedom from the classical negative aspects related to
the valve replacement surgery. When pooled together
they performed better than the mechanical AVR patients
in 5 of 8 questions. The risk of a valve failure remained
an occasional concern for one third of respondents
irrespective of the type of valve procedure. The risk of
reoperation was a substantial concern for the younger
valve repair patients (and surprisingly mechanical AVR
patients) but not for the older repair patients neither –
paradoxically – even for the Ross patients. The reason
for fear of reoperation in mechanical AVR patients in
contrast to less fear in the Ross patients remains unclear;
we can only speculate about a distrustful perception of
a “foreign” mechanical device on one hand and a vital
optimism of the Ross patients believing in the best
possible scenario on the other hand. Finally, to remind
the role of the self-report bias, all patients were equally
satisfied with the chosen type of the surgical procedure.
What information can be derived from these results?
While remaining cautious due to the small sample size
and the cross-sectional nature of QoL measurements,
differences in QoL do exist related to the type of valve
surgery. The Ross patients do generally very well after
the surgery. It is a highly selected population of young
active individuals who are very satisfied after having
chosen and successfully overcome a difficult surgical
strategy. In the light of optimal outcome and avoidance
of anticoagulation they do not worry too much about
the probable need for reoperation. In younger & mid-
aged patients who received valve sparing aortic proce-
dures similar scores of general health and valve-related
outcomes were found. The general quality of life in
older patients after valve-sparing aortic procedures was
lower but related to the valve procedure these patients
enjoy favorably the avoidance of anticoagulation and
are even less concerned by the risk of reoperation. The
patients after mechanical aortic valve replacement dis-
play consistently lower scores of QoL linked most prob-
ably to classical anticoagulation & prosthesis aspects.
While the QoL was reported to be excellent after
homograft replacement for aortic endocarditis [16] and
superior after Ross operation compared to the mechan-
ical replacement [17] the data on hypothesized beneficial
impact of valve-sparing procedures on QoL are very
limited. Franke et al. reported in 2010 a comparison of
QoL in 67 patients after aortic composite-graft replace-
ment vs 73 patients after David I procedure. Within a
3-years follow-up, both clinical results (incidence of
serious adverse events) and QoL assessed by SF-36
were inferior in the composite-graft replacement group.
The differences in QoL were significant in the age
groups below 50 and between 61 and 70 years [18]. In
2012, Aicher et al. published a comprehensive study
comparing QoL in patients after aortic valve repair,
mechanical AVR and Ross procedure. The upper age
limit in all groups was 45 years. In SF-36, they observed
similar scores and trend differences between the groups
in favor of the valve repair and Ross patients. In terms
of general and cardiac-related anxiety the levels were
increased relative to published norms in all three groups
without substantial differences related to the type of pro-
cedure. Valve-related concerns of the patients displayed
similar distribution of answers with the same level of post-
procedural satisfaction, although limitations and fears in
patients after mechanical AVR on chronic anticoagulation
were more frequent [19]. These results correlate with our
findings; we, moreover, studied also the older population
of valve repair patients who in real-life may be candidates
for valve repair as well.
Table 4 QoL expressed in relation to specific valve related concerns, acc. Perchinsky (modif.) [12] (Continued)
8. Are you disturbed by the risk of reoperation?
Never/rarely 28 60 59 41
Occasionally 56 31 32 52
Frequently/always 17 10 9 7
p value Y vs O - 0,013
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Study limitations
This is a non-randomized cross-sectional study; the
study population was derived from a single institutional
consecutive surgical volume during similar time interval.
The subgroups were defined with interest focused on
the impact of the type of the valve procedure; this, how-
ever, in the real life inevitably translates in some valvular
etiology differences. While every effort was invested in
repairing a purely regurgitant, pliable aortic valve, the
Ross procedure and mechanical AVR were undertaken
in cases of unrepairable regurgitation (retracted cusps)
and also a coexistent stenosis in some cases. Despite
these differences the groups were deemed comparable
due to their functional status and ejection fraction. No
assessments of QoL were performed pre-operatively and
therefore no comparison of individual changes from pre-
to post-surgery was possible. No attempts were made to
adjust the scores to the time elapsed since surgery nor
to stratify the patients (e.g., educational status) due to
the small study size. Finally, no patients were operated
from a miniinvasive approach the use of which might
potentially have influenced the postoperative QoL.
Conclusions
Quality of postoperative life is influenced by the specific
type of the aortic valve surgery. Procedures that enable
to avoid lifelong anticoagulation do translate into a higher
quality of life and greater freedom of disturbing valve-
related aspects. While the Ross procedure will probably
remain to be offered to a very selected population of
young active individuals, aortic valve repair should be
considered in all patients with suitable morphology for its
good clinical results and also a beneficial impact on the
quality of life. Postoperative quality of life and importance
of avoiding anticoagulation from the patient´s point of
view should motivate the surgeon to achieve expertise in
valve-sparing techniques.
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